Expression Pathology Inc.
Pioneering microproteomics in formalin fixed paraffin embedded tissue, Expression Pathology’s business addresses a major bottleneck and unmet need in drug and life science research. With a focus on...
www.expressionpathology.com/ View full profile
| |
F2G Ltd
F2G is advancing its own patented compounds and technologies which will lead to the development of novel agents to treat serious fungal disease.
The Company was founded on its proprietary...
www.f2g.com/ View full profile
| |
FAN GmbH
FAN GmbH - a centre of excellence for drug discovery with focus on diseases of the central nervous system Preclinical contract research - stroke and ischemia, Alzheimers disease,neuroprotection,...
www.fan-neuroscience.com/ View full profile
| |
FASgen, Inc.
FASgen, LLC, was formed in 1999 to access both therapeutic and diagnostic technologies based on the critical role played by fatty acid biosynthesis in health and disease. FASgen, LLC, holds exclusive...
www.fasgen.com/ View full profile
| |
FaustPharmaceuticals
Created in October 2001, FaustPharmaceuticals is a spin-off of the Centre National de Recherche Scientifique (CNRS), based on technologies developed by Dr. Maurice Israel. In November 2003,...
www.faustpharma.com/ View full profile
| |
Favrille
We are a biopharmaceutical company focused on the development and commercialization of patient-specific immunotherapies for the treatment of cancer and other diseases of the immune system. We own a...
www.favrille.com/ View full profile
| |
FermLab Ltd
FermLab Ltd., is a biotechnology company committed to providing life sciences R&D professionals with highest quality proteins for CNS disease, oncology and diagnostics area. Scientists and researchers...
www.fermlabs.com/ View full profile
| |
THE FOUNDATION FOR INNOVATION IN MEDICINE
FIM, The Foundation for Innovation in Medicine, was established in 1976 by Stephen L. DeFelice, M.D. It is a nonprofit foundation whose purpose is to accelerate medical discovery by creating a more...
www.fimdefelice.org/ View full profile
| |
Friedrich Miescher Institutefor Biomedical Research
Founded in 1970, the Friedrich Miescher Institute is devoted to fundamental biomedical research. We employ new technologies to explore basic molecular mechanisms of cells and organisms in health and...
www.fmi.ch/ View full profile
| |
Focus Diagnostics, Inc.
MissionFocus Diagnostics' mission is to be the early developer and market leader in innovative, high quality services for rare, unusual and emerging infectious and immunologic diseases. We strive to...
www.focusanswers.com/ View full profile
| |
Focus Diagnostics, Inc.
MissionFocus Diagnostics' mission is to be the early developer and market leader in innovative, high quality services for rare, unusual and emerging infectious and immunologic diseases. We strive to...
www.focusdx.com/ View full profile
| |
Galapagos
We are a genomics based drug discovery company, that has drug discovery programs based on proprietary disease modifying drug targets. Our vision is to bring novel drugs to the market in selected...
www.galadeno.com/ View full profile
| |
Galapagos
We are a genomics based drug discovery company, that has drug discovery programs based on proprietary disease modifying drug targets. Our vision is to bring novel drugs to the market in selected...
www.galapagosgenomics.com/ View full profile
| |
Foxhollow Technologies
An estimated 12 million people in the U.S. alone have peripheral arterial disease (PAD). At least 40% of them also suffer from coronary artery disease (CAD). FoxHollow recently launched the SilverHawk...
www.foxhollowtech.com/ View full profile
| |
Astellas Pharma US,Inc
Launched in April 2005, Astellas was formed by the historical merger of Japan's third and fifth largest pharmaceutical companies - Yamanouchi, founded in 1923, and Fujisawa, founded in 1894.Both...
www.fujisawa.com/ View full profile
| |
